BAROCCI, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 112
NA - Nord America 54
SA - Sud America 39
EU - Europa 30
AF - Africa 3
Totale 238
Nazione #
US - Stati Uniti d'America 50
VN - Vietnam 36
BR - Brasile 32
SG - Singapore 24
CN - Cina 23
HK - Hong Kong 21
RU - Federazione Russa 9
IT - Italia 8
AR - Argentina 3
DE - Germania 3
FR - Francia 3
UA - Ucraina 3
EC - Ecuador 2
IN - India 2
JP - Giappone 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FI - Finlandia 1
IE - Irlanda 1
KE - Kenya 1
NI - Nicaragua 1
NL - Olanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 238
Città #
Hong Kong 21
Dallas 14
Ho Chi Minh City 13
Ashburn 11
Singapore 11
Hanoi 8
San Jose 6
Beijing 4
Dongguan 4
New York 4
São Paulo 4
Guangzhou 3
Hefei 3
Lauterbourg 3
Orem 3
Urbisaglia 3
Belo Horizonte 2
Buffalo 2
Kyiv 2
Mugnano di Napoli 2
Ninh Bình 2
Nuremberg 2
Qingdao 2
Salt Lake City 2
Abaetetuba 1
Amsterdam 1
Araraquara 1
Baku 1
Betim 1
Blida 1
Bratislava 1
Buenos Aires 1
Camaçari 1
Campinas 1
Catanduva 1
Caxias do Sul 1
Centro 1
Congonhas 1
Council Bluffs 1
Da Nang 1
Dublin 1
Durban 1
Eagleville 1
Espumoso 1
Glew 1
Gravataí 1
Haiphong 1
Helsinki 1
Huế 1
Hải Dương 1
Ibiúna 1
Ipirá 1
Iporá 1
Itanhaém 1
Joinville 1
Karachi 1
Laguna 1
Londrina 1
Los Angeles 1
Managua 1
Manta 1
Mogi das Cruzes 1
Montevideo 1
Moscow 1
Mérida 1
Nagasaki 1
Nairobi 1
Oncativo 1
Ortona 1
Parobé 1
Passos 1
Pereira 1
Phoenix 1
Phủ Lý 1
Pokrovske 1
Quito 1
Quảng Ngãi 1
Ribeirão Preto 1
Rio Tinto 1
Salvador 1
Samālkha 1
Santo Domingo 1
Segrate 1
São Gonçalo 1
São José dos Campos 1
Taboão da Serra 1
Thanh Hóa 1
Tokyo 1
Tân Tiến 1
Vĩnh Tường 1
Totale 197
Nome #
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 80
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 74
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 70
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 26
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis? 4
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study 2
Totale 256
Categoria #
all - tutte 600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202551 0 0 0 0 0 0 0 0 15 32 0 4
2025/2026205 2 27 24 36 14 5 34 27 14 22 0 0
Totale 256